Brain function, quantified.
Precision biomarkers of brain function -
Accurate, reliable, and built for scale.
Recent news
Measuring what matters most
For decades, neurology has chased a bold vision for quantifying brain function: measurements that are objective, direct, and accurate enough to detect meaningful change.
NeuraLight's precision biomarkers deliver on that vision - quantifying performance of visual tasks that engage distinct neural pathways, through one of the most direct windows into brain function known to science: the eyes.
From function to biomarkers
NeuraLight's software-based platform pairs visual tasks designed to engage specific brain functions with pioneering AI - translating performance into objective, quantitative measures of targeted brain regions.
Built at the Intersection of neuroscience and technology
A founding team spanning neuroscience, clinical neurology, mathematics, and health technology — guided by the conviction that brain function can be made accurately measurable. Endorsed by leading neurologists, Nobel laureates, and major research foundations.
Award-winning mathematician with 20+ years designing novel AI algorithms. Repeat entrepreneur.
Eddy is a repeat entrepreneur and an award-winning mathematician, with over 20 years of experience designing novel AI algorithms and building world-class teams to take on some of the most challenging technological challenges in signal processing, computer vision, and AI.
.png)
World-renowned technologist. Former CTO of Flatiron Health, acquired by Roche for $2B.
Gil is a world-renowned technologist, who previously served as CTO of Flatiron Health (acquired by Roche for $2B) growing the technology team from two engineers to a team of over 350 across software, DevOps, IT, security, product design, and data science. At NeuraLight he is responsible for all cross-functional scaling and growth, and is also an avid startup investor, advisor and mentor.
Nobel laureate neuroscientist for his work on synaptic transmission. Leading Alzheimer's disease researcher.
Prof. Südhof is a world-renowned neuroscientist who won a Nobel prize for his work on synaptic transmission. Currently heading the Südhof lab at Stanford, he’s considered by many one of the world’s leading researchers of Alzheimer’s Disease.
He has published over 500 scientific papers and is widely recognized for identifying key synaptic proteins such as synaptotagmins and neurexins. In addition to the Nobel Prize, he has received numerous honors, including the Lasker Award and the Kavli Prize, for his contributions to neuroscience.
World-renowned neurologist and clinical pharmacologist. Expert in Parkinson's and movement disorders. Head of the French research network.
Prof. Rascol is a world-renowned neurologist and clinical pharmacologist, an expert in Parkinson’s and movement disorders, as well as drug development for PD. Prof. Rascol has served as the secretary of the International Parkinson & Movement Disorders Society and as the Chair of its European section. He is either serving or has previously served as associate editor for the Movement Disorder Journal, the Journal of Neural Transmission and as a member of the editorial board of Lancet Neurology, Neurology, CNS Drugs and the European Journal of Neurology, and has published more than 500 articles in international scientific journals.